SEC EDGAROCT 131 min read$SNEX

OCONNOR SEAN MICHAEL sold $4.6M of SNEX

OCONNOR SEAN MICHAEL (Executive Vice-Chairman-Board) sold 76,148 shares of StoneX Group Inc. (SNEX) at $60.35 ($4.60M total) on 2026-10-12 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · OCONNOR SEAN MICHAEL

Published Oct 13, 2026, 11:06 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 13, 2026, 11:09 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$SNEX

Bearish

medium confidence

Mentioned

$SNEX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$SNEXBearishLow

Why it matters

The transaction is a material insider sale that could influence short‑term price action, especially given the seniority of the insider.

Market read

The filing is the first public disclosure of this insider sale, offering new information for traders assessing SNEX.

What to watch

The insider retains a large stake (over 1.8M shares) and the sale represents a small percentage of total holdings.

Relevance 5/10Novelty 8/10Timing: after‑hours filing on 2026‑10‑13

Background

SEC Form 4 filings provide primary disclosure of insider transactions. This filing reports a $4.6M sale by StoneX Group's Executive Vice‑Chairman.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$SNEXBearishMedium confidence

Context

Executive Vice-Chairman Sean Michael O'Connor sold 76,148 shares for $4.6M via a 10b5‑1 plan, reducing his stake to 1.83M shares.

Expected impact

likely downward pressure as the market prices the insider sell

Evidence & confidence

A sizable insider sale of $4.6M from a senior officer can be interpreted as a negative signal, though the transaction is pre‑arranged under a 10b5‑1 plan.

Market effects

Sector

May affect perception of the broader brokerage and financial services sector if investors view insider sales as a red flag.

Regional

Limited to U.S. markets where SNEX trades.

Global

Minimal global impact.

Counterpoint

What could challenge this read

The sale was pre‑arranged under a 10b5‑1 plan and may not reflect current sentiment; the stock could remain stable.

Key entities

Company
StoneX Group Inc.
U.S. listed brokerage and financial services firm (ticker SNEX).
Individual
Sean Michael O'Connor
Executive Vice‑Chairman and director of StoneX Group.

Read at source ← All news

OCT 22

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

investing.com2 min

OCT 19

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

investing.com2 min

OCT 16

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

investing.com1 min

OCT 15

$ONMed

Onsemi started at Buy at StoneX, sees 54% upside on chip growth (ON:NASDAQ)

StoneX initiated coverage of ON Semiconductor (ON) with a Buy rating, citing potential benefits from semiconductor demand recovery and growth in automotive and AI data center power systems. The stock is down 3% in premarket trading.

seekingalpha.com1 min

OCT 15

$ONMed

ON Stock Draws Bullish Initiation From StoneX — Analyst Sees Nearly 50% Upside On Broadening Chip Recovery

Onsemi (ON) guided Q3 revenue between $1.65B and $1.75B, up from $1.6B in Q2. StoneX initiated coverage with a bullish outlook, suggesting nearly 50% upside. Retail sentiment on Stocktwits is 'extremely bearish,' despite a 29% year-to-date rally for ON shares, compared to a 65% rise in the iShares Semiconductor ETF (SOXX).

finance.yahoo.com1 min

OCT 14

$DPZMed

StoneX maintains Buy rating on Domino's Pizza, $400 price target

StoneX maintained a Buy rating on Domino's Pizza (DPZ) with a $400 price target, implying a 35.1% upside from the Oct 13 close. The firm cited strong traffic growth drivers and attractive valuation relative to historical ranges. Recent analyst price targets for DPZ range from $320 to $425.

tradingview.com1 min